MHLW Alerts On Iressa And Tarceva Death Cases
This article was originally published in PharmAsia News
Executive Summary
The Ministry of Health, Labor and Welfare had requested caution in use of anticancer drugs Iressa (gefitinib) and Tarceva(erlotinib)